Bio-Path Holdings Company Profile (NASDAQ:BPTH)

About Bio-Path Holdings

Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize, is a platform that uses P-ethoxy, a deoxyribonucleic acid backbone modification. Its lead drug candidate, Liposomal Grb2 (BP1001), targets the protein Growth factor receptor-bound protein 2 (Grb2). Its other liposome delivered antisense drug candidate, Liposomal Bcl2 (BP1002), targets the protein B-cell lymphoma 2 (Bcl2). BP1001 is in Phase II clinical trials for acute myeloid leukemia, and for blast phase and accelerated phase chronic myelogenous leukemia. BP1002 is intended to target the lymphoma and certain solid tumor markets. BP1001 is also in preclinical studies for solid tumors, including triple negative breast cancer and inflammatory breast cancer.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drug Delivery
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: BPTH
CUSIP:

Key Metrics:

Previous Close: $1.36
50 Day Moving Average: $1.55
200 Day Moving Average: $2.09
52-Week Range: $1.05 - $3.19
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -15.33
P/E Growth: 0.00
Market Cap: $130.08M
Outstanding Shares: 95,645,000
Beta: 1.52

Profitability:

Return on Equity: -77.03%
Return on Assets: -70.74%

Debt:

Current Ratio: 7.49%
Quick Ratio: 7.49%

Additional Links:

Companies Related to Bio-Path Holdings:

Consensus Ratings for Bio-Path Holdings (NASDAQ:BPTH) (?)

Ratings Breakdown:	2 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$3.50 (153.62% upside)

Analysts' Ratings History for Bio-Path Holdings (NASDAQ:BPTH)

Show:

Date	Firm	Action	Rating	Price Target	Details
8/11/2016	Rodman & Renshaw	Set Price Target	Buy	$5.00
8/10/2016	Maxim Group	Lower Price Target	Buy	$5.00 -> $2.00

(Data available from 9/28/2014 forward)

Earnings History for Bio-Path Holdings (NASDAQ:BPTH)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Release Link	Conference Call
11/8/2016
8/10/2016	Q2	($0.02)	($0.02)		View	N/A
5/11/2016	Q1	($0.01)	($0.02)	$2.33 million	View	Listen
3/15/2016	Q4	($0.01)	($0.02)		View	N/A
3/17/2015		$0.01	($0.02)		View	N/A
11/18/2014		($0.01)	($0.01)		View	N/A
8/18/2014	Q214	($0.01)	($0.01)		View	N/A
4/2/2014		$0.01	$0.01		View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Bio-Path Holdings (NASDAQ:BPTH)

Current Year EPS Consensus Estimate: $-0.08 EPS
Next Year EPS Consensus Estimate: $-0.09 EPS

Dividend History for Bio-Path Holdings (NASDAQ:BPTH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Bio-Path Holdings (NASDAQ:BPTH)

Insider Ownership Percentage: 13.13%
Institutional Ownership Percentage: 20.50%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/13/2015	Michael J Garrison	Director	Buy	7,343	$1.22	$8,958.46
7/9/2015	Michael J Garrison	Director	Buy	8,724	$1.17	$10,207.08
7/8/2015	Michael J Garrison	Director	Buy	60,000	$1.19	$71,400.00

(Data available from 1/1/2013 forward)

Latest Headlines for Bio-Path Holdings (NASDAQ:BPTH)

Date	Headline
	Penny Stock Investors are Growing Curious About Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 27 at 3:53 PM
	Keen Investors Find News on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 23 at 3:23 PM
	Bio-Path Holdings's Buy Rating Reiterated at Maxim Group (BPTH) - Petro Global News 24 (NASDAQ:BPTH) petroglobalnews24.com - September 23 at 9:00 AM
	Under the Microscope, Zeroing in at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 23 at 9:00 AM
	Penny Stock Investors Keen on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 21 at 3:22 PM
	Penny Stock Investors Take an Interest in Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 21 at 8:29 AM
	Bio-Path Holdings Inc (BPTH) Given “Buy” Rating at Maxim Group - DailyQuint (NASDAQ:BPTH) dailyquint.com - September 21 at 8:29 AM
	Keen Investors Seek Information on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 16 at 12:32 PM
	Stock Update, a Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 15 at 3:47 PM
	Keen Investors Narrowing Their Focus on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 14 at 3:56 PM
	Penny Stock Investors Highly Curious in Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 13 at 5:50 PM
	Getting a Closer Look at Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 12 at 3:50 PM
	Making News: Targeting shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 10 at 8:39 AM
	Focusing the Spotlight on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 8 at 3:50 PM
	Narrowing the Lens on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 7 at 3:56 PM
	Bio-Path Holdings to Present at the Rodman & Renshaw 18th Annual Global Investment Conference - GlobeNewswire (press release) (NASDAQ:BPTH) globenewswire.com - September 6 at 8:53 PM
	OTC Investors Supremely Interested in Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 6 at 8:53 PM
	Bio-Path Holdings to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:BPTH) finance.yahoo.com - September 6 at 8:47 AM
	A Second Look at Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 2 at 3:46 PM
	Taking a Serious Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 1 at 12:24 PM
	Under the Magnifying Glass: A Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - September 1 at 12:24 PM
	Zeroing Our Focus on Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 30 at 11:46 AM
	Penny Stock Under the Microscope: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 26 at 12:00 PM
	OTC Investors Keen on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 26 at 12:00 PM
	Looking Closer at Stocks of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 25 at 8:50 AM
	Let's Take a Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 23 at 8:06 AM
	Stock Tracking Lower for the Quarter: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Post News (NASDAQ:BPTH) www.kentuckypostnews.com - August 21 at 8:38 AM
	Small Cap Insight on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 20 at 3:56 PM
	BIO-PATH HOLDINGS INC Financials (NASDAQ:BPTH) finance.yahoo.com - August 19 at 4:36 PM
	Penny Stock Alert - Update & Review on This Stock: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 19 at 12:18 PM
	A Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 17 at 12:05 PM
	Taking A Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 17 at 12:05 PM
	Small Cap Update on: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH) www.duncanindependent.com - August 15 at 4:03 PM
	Bio-Path reports 2Q loss (NASDAQ:BPTH) www.cnbc.com - August 10 at 9:24 PM
	Bio-Path Holdings Reports Second Quarter 2016 Financial Results (NASDAQ:BPTH) globenewswire.com - August 10 at 9:24 PM
	Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2016 Results - Earnings Call Transcript (NASDAQ:BPTH) seekingalpha.com - August 10 at 9:24 PM
	Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:BPTH) seekingalpha.com - August 10 at 3:23 PM
	BIO-PATH HOLDINGS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:BPTH) biz.yahoo.com - August 10 at 3:23 PM
	Bio-Path Holdings to Announce Second Quarter 2016 Financial Results on August 10, 2016 (NASDAQ:BPTH) finance.yahoo.com - August 3 at 12:39 PM
	BIO-PATH HOLDINGS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exh (NASDAQ:BPTH) biz.yahoo.com - August 2 at 8:43 AM
	Stock Displaying Signs of a Downtrend: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Press Telegraph (NASDAQ:BPTH) presstelegraph.com - July 23 at 3:53 PM
	Bio Path Holdings DE (NASDAQ:BPTH) Shorted Shares Increased By 216.62% - Consumer Eagle (NASDAQ:BPTH) www.consumereagle.com - July 19 at 3:57 PM
	Top News: Bio-Path Holdings, Inc. (NASDAQ:BPTH), Great Basin Scientific, Inc. (NASDAQ:GBSN), Acasti Pharma Inc ... - KC Register (NASDAQ:BPTH) www.kcregister.com - July 19 at 10:10 AM
	Bio-Path Holdings (BPTH) Updated Price Targets - FTSE News (NASDAQ:BPTH) www.ftsenews.co.uk - July 19 at 10:10 AM
	Shares Moving Down on the Week: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH) www.engelwooddaily.com - July 17 at 3:47 PM
	Shares Experiencing a Downtrend: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - TGP (NASDAQ:BPTH) telanaganapress.com - July 16 at 8:28 AM
	Share Volatility Watch for: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH) www.engelwooddaily.com - July 13 at 12:02 PM
	Bio-path Holdings Inc (NASDAQ:BPTH) Sentiment Change Report - Consumer Eagle (NASDAQ:BPTH) www.consumereagle.com - July 13 at 12:02 PM
	Bio-Path Holdings to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference (NASDAQ:BPTH) finance.yahoo.com - July 6 at 8:00 AM
	Houston biotech firm collaborates with university on brain cancer therapy (NASDAQ:BPTH) www.bizjournals.com - July 5 at 3:57 PM